Drug Class Reviews
by Drug Effectiveness Review Project
Publisher: Oregon Health & Science University 2009
Contents: Agents for Overactive Bladder; Alzheimer's Drugs; Atypical Antipsychotic Drugs; Beta Adrenergic Blockers; Beta2-Agonists; Calcium Channel Blockers; Constipation Drugs; Disease-modifying drugs for Multiple Sclerosis; HMG-CoA Reductase Inhibitors; Inhaled Corticosteroids; Long-Acting Opioid Analgesics; Drugs for Neuropathic Pain; Newer Antiemetics; Newer Antihistamines; Newer Antiplatelet Agents; Newer Drugs for Insomnia; Oral Hypoglycemics; etc.
Home page url
Download or read it online for free here:
(multiple PDF files)
- National Academies Press
Objectives: to examine the impact of and investment in genetic and genomic technologies and data in drug development; to examine the challenges for incorporating genomic technologies into drug development and to to remedy those challenges.
- International Agency for Research on Cancer
This volume provides an assessment of the carcinogenicity of 14 drugs and herbal products. The authors relied on epidemiological studies to evaluate the carcinogenic hazard to humans exposed to the drugs digoxin, pioglitazone and hydrochlorothiazide.
- U.S. Department of Health and Human Services
The publication, Approved Drug Products (commonly known as the Orange Book), identifies drug products approved on the basis of safety and effectiveness by the Food and Drug Administration (FDA) under the Federal Food, Drug, and Cosmetic Act.
by Kenneth L Davis, at al. - Lippincott Williams & Wilkins
This book establishes a critical bridge connecting new discoveries in molecular and cellular biology, genetics, and neuroimaging with the etiology, diagnosis, and treatment of the full spectrum of neuropsychiatric disorders.